Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 5/20 | 0.36 |
| ▸ | NOS1 | P29475 | 5/20 | 0.36 |
| ▸ | NOS2 | P35228 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isobutane SCHEMBL1229517 | 0.87 | SPHK2 (0.38) | SPHK2SPHK1NOS3NOS1NOS2 | |
| SCHEMBL12181 | 0.86 | — | — | |
| Water SCHEMBL30816099 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL2689253 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL166054 | 0.82 | — | — | |
| Hydrazine SCHEMBL10430760 | 0.82 | — | — | |
| Iodide SCHEMBL30575029 | 0.82 | — | — | |
| SCHEMBL21351628 | 0.73 | — | — | |
| Bicarbonate SCHEMBL6620515 | 0.73 | — | — | |
| Acetic Acid SCHEMBL21807691 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10913754-B2 | Lanthanum compound and methods of forming thin film and integrated circuit device using the lanthanum compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-02-09 | — | — | US | disclosed |
| US-20190152996-A1 | LANTHANUM COMPOUND AND METHODS OF FORMING THIN FILM AND INTEGRATED CIRCUIT DEVICE USING THE LANTHANUM COMPOUND | ADEKA CORPORATION (JP) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152996-A1 | LANTHANUM COMPOUND AND METHODS OF FORMING THIN FILM AND INTEGRATED CIRCUIT DEVICE USING THE LANTHANUM COMPOUND | C5, C9, C1R | SPHK2 1898/4885SPHK1 1754/4885NOS3 1687/4885 |
| US-10913754-B2 | Lanthanum compound and methods of forming thin film and integrated circuit device using the lanthanum compound | C5, C9, C1R | SPHK2 1898/4885SPHK1 1754/4885NOS3 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.